Records containing: Stage IVB Prostate Cancer AJCC v8

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-24
DS3201 With Ipilimumab in Patients With Metastatic Aggressive Variant Prostate (AVPC), Urothelial (UC), and Renal Cell (RCC) Carcinomas
CLINICAL_TRIALS study record update · 2026-04-23
Bipolar Androgen Therapy in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
CLINICAL_TRIALS study record update · 2026-04-22
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
CLINICAL_TRIALS study record update · 2026-04-20
Pilot Study of ¹⁷⁷Lu-PSMA-617 in Combination With Sipuleucel-T in Patients With Metastatic Castration-Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2026-04-17
A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, &Amp; Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-04-15
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
CLINICAL_TRIALS study record update · 2026-04-15
A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)
CLINICAL_TRIALS study record update · 2026-04-14
A Phase 2 Study of M1774 in Refractory SPOP-Mutant Prostate Cancer
CLINICAL_TRIALS study record update · 2026-04-13
A First-in-Human Dose-Finding Phase I Study of Bone-targeted High Specific Activity Stannic-117m Pentatate (Sn-117m-DTPA) in Solid Tumors With Skeletal Metastases
CLINICAL_TRIALS study record update · 2026-04-13
Cancer Moonshot Biobank Research Protocol
CLINICAL_TRIALS study record update · 2026-04-13
Phase I/II Study of CDK4/6 Inhibition With Abemaciclib to Upregulate PSMA Expression Prior to 177Lu-PSMA-617 Treatment in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) Previously Treated With Novel Hormonal Agents and Chemotherapy
CLINICAL_TRIALS study record update · 2026-04-13
Study of JAK Inhibition in Stem-Like Prostate Cancer (JASPER): A Phase 1b/2a Multicenter Study of Ruxolitinib and Enzalutamide in Castration Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2026-04-08
A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)
CLINICAL_TRIALS study record update · 2026-04-07
PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)
CLINICAL_TRIALS study record update · 2026-04-07
Docetaxel Addition in Metastatic Castrate-Sensitive Prostate Cancer (ASPIRE)
CLINICAL_TRIALS study record update · 2026-04-03
Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)
CLINICAL_TRIALS study record update · 2026-03-30
Radiologically Guided Biopsies of Metastatic Castration Resistant Prostate Cancer to Identify Mechanisms of Resistance in Patients Undergoing 177Lu-PSMA Radioligand Therapy
CLINICAL_TRIALS study record update · 2026-03-30
A Randomized Open Label Phase II Trial of FDG-PET-Guided Metastasis Directed Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer: PRTY Trial: PET- Guided Radiotherapy Consolidation
CLINICAL_TRIALS study record update · 2026-03-24
A Phase 2 Study of Biomarker-Modulated PSMA Theranostics
CLINICAL_TRIALS study record update · 2026-03-16
A Phase 2, Study of Apalutamide and Abiraterone Acetate in Castration-Resistant Metastatic Prostate Cancer Patients Evaluating a Predetermined Biomarker Signature
CLINICAL_TRIALS study record update · 2026-03-13
Re-Treatment With 177Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer: A Prospective Phase 2 Trial (RE-LuPSMA STUDY)
CLINICAL_TRIALS study record update · 2026-03-12
Estrogen for Quality-of-Life and Immune Modulation in Prostate Cancer (EQUIP)
CLINICAL_TRIALS study record update · 2026-02-19
A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
CLINICAL_TRIALS study record update · 2026-02-17
The Impact of DNA Repair Pathway Alterations Identified by Circulating Tumor DNA on Sensitivity to Radium-223 in Bone Metastatic Castration-Resistant Prostate Cancer
CLINICAL_TRIALS study record update · 2026-02-17
Phase 1/2 Dose-Escalation and Cohort Study of STEAP1 CART With Enzalutamide in Participants With mCRPC